3,198
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Erythrocyte Sedimentation Rate—A Predictor of Malignant Potential in Early Prostate Cancer

, &
Pages 689-694 | Received 18 Apr 1997, Accepted 16 Jul 1997, Published online: 08 Jul 2009

References

  • Parker L S, Tong T, Bolden S, Wingo PA. Cancer statistics 1996. CA 1996; 65: 5–27
  • Engeland A, Haldorsen T, Hakulinen T, Hörte L G, Luostarinen T, Magnus K, et al. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. APMIS 1993; 38: 64–6
  • Meikle A W, Smith JA. Epidemiology of prostate cancer. Urol Clin North Am 1990; 17: 709–18
  • Aus G, Hugosson J, Norlén L. Longterm survival and mortality in prostate cancer treated with noncurative intent. J Urol 1995; 154: 460–5
  • Borre M, Nerstrøm B, Overgaard J. The natural history of prostate carcinoma based on a Danish population treated with no intent of cure. Cancer 1997; 80: 917–28
  • Scardino PT. Early detection of prostate cancer. Hum Pathol 1992; 23: 211–22
  • Smith D S, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994; 152: 1732–6
  • Imai Suzuki K. T, Kobayashi M, Yamanaka H, Tomaru Y, Sato J. The significance of erythrocyte sedimentation rate as a prognostic factor for patients with prostate cancer. Jpn J Cancer Res 1990; 81: 971–4
  • Johansson J E, Sigurdsson T, Holmberg L, Bergström R. Erythrocyte sedimentation rate as a tumor marker in human prostatic cancer. An analysis of prognostic factors in 300 population-based consecutive cases. Cancer 1992; 70: 1556–63
  • Hannisdal E, Fosså SD, Høst H. Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy. Radiother Oncol 1993; 27: 117–22
  • Jacobsen E B, Eichoff J H, Andersen J P, Ottesen M. Prognosis after nephrectomy for renal cell carcinoma. Scand J Urol Neprol 1994; 28: 229–36
  • Hannisdal E, Gundersen S, Kvaløy S, Lindegaard M W, Aas M, Finnanger A M, et al. Follow-up of breast cancer patients stage I–II: a baseline strategy. Eur J Cancer 1993; 29a: 992–7
  • Hannisdal E, Tveit K M, Theodorsen L, Høst H. Host markers and prognosis in recurrent rectal carcinomas treated with radiotherapy. Acta Oncol 1994; 33: 415–21
  • Hannisdal E, Engan T. Blood analyses and survival in symptom- and survey-detected lung cancer patients. J Int Med 1991; 229: 337–341
  • Westergren A. Studies of the suspension stability of the blood in pulmonary tuberculosis. Acta Med Scand 1921; 54: 247–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.